Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma

Abstract Background This study aims to evaluate the efficacy and safety of camrelizumab in combination with chemotherapy as a second-line treatment for patients with locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma (ESCC). Methods In this retrospective, single-center obs...

Full description

Saved in:
Bibliographic Details
Main Authors: Yinfang Gu, Xiaofang Zou, Junlin Zhu, Guowu Wu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-025-03690-9
Tags: Add Tag
No Tags, Be the first to tag this record!